Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
STAT+
Health
Biotech
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

Thermo Fisher buys contract-research company PPD for $17.4 billion

By Anissa Gardizy — Boston GlobeApril 15, 2021

Reprints
Thermo Fisher Scientific
Suzanne Kreiter/The Boston Globe

Thermo Fisher Scientific announced Thursday that it will buy PPD, a contract-research company for the pharmaceutical and biotech industries, in a deal valued at $17.4 billion, plus the assumption of about $3.5 billion in debt.

The acquisition will allow Waltham-based Thermo Scientific, a leader in laboratory equipment and services, to expand its reach in life sciences. PPD, based in North Carolina, provides services to help drug companies run clinical trials.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Anissa Gardizy — Boston Globe

Tags

Experts weigh in on potential health hazards posed by…
Experts weigh in on potential health hazards posed by chemicals in Ohio train derailment
With overdoses at record highs, a veterinary tranquilizer spreading…
With overdoses at record highs, a veterinary tranquilizer spreading through the U.S. drug supply poses new…
Long-term study shows most prostate cancer patients don’t need…
Long-term study shows most prostate cancer patients don’t need aggressive treatment
Patient groups balk at former AstraZeneca official negotiating U.K.-India…
Patient groups balk at former AstraZeneca official negotiating U.K.-India free trade deal
Altimmune’s obesity drug fails to stand out from blockbuster…
Altimmune’s obesity drug fails to stand out from blockbuster treatments in early data
Pharmalittle: FDA official wants to use accelerated approval for…
Pharmalittle: FDA official wants to use accelerated approval for gene therapies; pharma asks Biden for tax…

Recommended Stories